{"id":"W3182206294","doi":"10.1016/j.ejca.2021.05.037","title":"Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Oncology; Metastatic breast cancer; Breast cancer; Placebo; Population; Clinical endpoint; Surgery; Cancer; Confidence interval; Chemotherapy; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001322079,0.0002019923,0.001405809,0.0002739578,0.00003244591,0.00001013927,0.00008700345,0.00004735161,0.0002253986],"category_scores_gemma":[0.0002387262,0.0001539913,0.0002379292,0.0006885811,0.0002269951,0.0001056287,0.00003711318,0.00036331,1.442956e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001025868,"about_ca_system_score_gemma":0.0002947613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005401512,"about_ca_topic_score_gemma":0.0002434249,"domain_scores_codex":[0.9966777,0.0005306564,0.00181601,0.0002838593,0.0005033161,0.0001884576],"domain_scores_gemma":[0.9969404,0.0003786302,0.001393465,0.0002534184,0.000818605,0.0002154522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4887715,0.0007398471,0.4536461,0.0001153126,0.002287511,0.00008359173,0.000451262,0.001678648,0.0004087121,0.000002734673,0.00005340434,0.05176146],"study_design_scores_gemma":[0.3578523,0.001344876,0.6376666,0.0007536245,0.001382233,0.00001244858,0.00003487204,0.0001116316,0.0001930299,0.000001533027,0.0005408265,0.000105998],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928461,0.005057759,0.0001533676,0.0008841479,0.0002428946,0.000441811,0.0002271148,0.000004691595,0.0001421519],"genre_scores_gemma":[0.992937,0.005994545,0.0004681101,0.0001692197,0.0003312846,0.000005856664,0.00001696499,0.00003415325,0.00004282496],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1840205,"threshold_uncertainty_score":0.6279584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02218394774989134,"score_gpt":0.3362273108954843,"score_spread":0.3140433631455929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}